A citation-based method for searching scientific literature

David M Ornitz, Nobuyuki Itoh. Wiley Interdiscip Rev Dev Biol 2015
Times Cited: 874







List of co-cited articles
564 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Advances and challenges in targeting FGFR signalling in cancer.
Irina S Babina, Nicholas C Turner. Nat Rev Cancer 2017
292
12


FGF/FGFR signaling in health and disease.
Yangli Xie, Nan Su, Jing Yang, Qiaoyan Tan, Shuo Huang, Min Jin, Zhenhong Ni, Bin Zhang, Dali Zhang, Fengtao Luo,[...]. Signal Transduct Target Ther 2020
44
25

Fibroblast growth factor signalling: from development to cancer.
Nicholas Turner, Richard Grose. Nat Rev Cancer 2010
10

Cell signaling by receptor tyrosine kinases.
Mark A Lemmon, Joseph Schlessinger. Cell 2010
9

Targeting FGFR Signaling in Cancer.
Mehdi Touat, Ecaterina Ileana, Sophie Postel-Vinay, Fabrice André, Jean-Charles Soria. Clin Cancer Res 2015
257
9

Cellular signaling by fibroblast growth factor receptors.
V P Eswarakumar, I Lax, J Schlessinger. Cytokine Growth Factor Rev 2005
8

The FGF family: biology, pathophysiology and therapy.
Andrew Beenken, Moosa Mohammadi. Nat Rev Drug Discov 2009
8

Fibroblast Growth Factor Receptors (FGFRs): Structures and Small Molecule Inhibitors.
Shuyan Dai, Zhan Zhou, Zhuchu Chen, Guangyu Xu, Yongheng Chen. Cells 2019
69
11

Exploring mechanisms of FGF signalling through the lens of structural biology.
Regina Goetz, Moosa Mohammadi. Nat Rev Mol Cell Biol 2013
316
8

Genetic insights into the mechanisms of Fgf signaling.
J Richard Brewer, Pierre Mazot, Philippe Soriano. Genes Dev 2016
104
7


Transforming fusions of FGFR and TACC genes in human glioblastoma.
Devendra Singh, Joseph Minhow Chan, Pietro Zoppoli, Francesco Niola, Ryan Sullivan, Angelica Castano, Eric Minwei Liu, Jonathan Reichel, Paola Porrati, Serena Pellegatta,[...]. Science 2012
471
6

Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study.
Martin Schuler, Byoung Chul Cho, Cyrus Michael Sayehli, Alejandro Navarro, Ross A Soo, Heike Richly, Philippe Alexandre Cassier, David Tai, Nicolas Penel, Lucia Nogova,[...]. Lancet Oncol 2019
56
10

Erdafitinib in Locally Advanced or Metastatic Urothelial Carcinoma.
Yohann Loriot, Andrea Necchi, Se Hoon Park, Jesus Garcia-Donas, Robert Huddart, Earle Burgess, Mark Fleming, Arash Rezazadeh, Begoña Mellado, Sergey Varlamov,[...]. N Engl J Med 2019
345
6

Fibroblast growth factors: key players in regeneration and tissue repair.
Luigi Maddaluno, Corinne Urwyler, Sabine Werner. Development 2017
84
7

The FGFR Landscape in Cancer: Analysis of 4,853 Tumors by Next-Generation Sequencing.
Teresa Helsten, Sheryl Elkin, Elisa Arthur, Brett N Tomson, Jennifer Carter, Razelle Kurzrock. Clin Cancer Res 2016
279
6

Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis.
Sunday S Oladipupo, Craig Smith, Andrea Santeford, Changwon Park, Abdoulaye Sene, Luke A Wiley, Patrick Osei-Owusu, Joann Hsu, Nicole Zapata, Fang Liu,[...]. Proc Natl Acad Sci U S A 2014
79
7


Identification of targetable FGFR gene fusions in diverse cancers.
Yi-Mi Wu, Fengyun Su, Shanker Kalyana-Sundaram, Nickolay Khazanov, Bushra Ateeq, Xuhong Cao, Robert J Lonigro, Pankaj Vats, Rui Wang, Su-Fang Lin,[...]. Cancer Discov 2013
433
5

Multicenter Phase I Study of Erdafitinib (JNJ-42756493), Oral Pan-Fibroblast Growth Factor Receptor Inhibitor, in Patients with Advanced or Refractory Solid Tumors.
Rastislav Bahleda, Antoine Italiano, Cinta Hierro, Alain Mita, Andres Cervantes, Nancy Chan, Mark Awad, Emiliano Calvo, Victor Moreno, Ramaswamy Govindan,[...]. Clin Cancer Res 2019
86
5

Functional proteomics defines the molecular switch underlying FGF receptor trafficking and cellular outputs.
Chiara Francavilla, Kristoffer T G Rigbolt, Kristina B Emdal, Gianni Carraro, Erik Vernet, Dorte B Bekker-Jensen, Werner Streicher, Mats Wikström, Michael Sundström, Saverio Bellusci,[...]. Mol Cell 2013
93
5

Molecular mechanisms of fibroblast growth factor signaling in physiology and pathology.
Artur A Belov, Moosa Mohammadi. Cold Spring Harb Perspect Biol 2013
140
5

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
5


Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.
Marco Presta, Paola Chiodelli, Arianna Giacomini, Marco Rusnati, Roberto Ronca. Pharmacol Ther 2017
88
5

Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family.
Xiuqin Zhang, Omar A Ibrahimi, Shaun K Olsen, Hisashi Umemori, Moosa Mohammadi, David M Ornitz. J Biol Chem 2006
792
5

Targeting the fibroblast growth factor receptor family in cancer.
Niamh Hallinan, Stephen Finn, Sinead Cuffe, Shereen Rafee, Kenneth O'Byrne, Kathy Gately. Cancer Treat Rev 2016
71
7

Fibroblast growth factors and their receptors in cancer.
Jørgen Wesche, Kaisa Haglund, Ellen Margrethe Haugsten. Biochem J 2011
349
5

FGFR1 mRNA and protein expression, not gene copy number, predict FGFR TKI sensitivity across all lung cancer histologies.
Murry W Wynes, Trista K Hinz, Dexiang Gao, Michael Martini, Lindsay A Marek, Kathryn E Ware, Michael G Edwards, Diana Böhm, Sven Perner, Barbara A Helfrich,[...]. Clin Cancer Res 2014
123
4

Molecular pathways: fibroblast growth factor signaling: a new therapeutic opportunity in cancer.
A Nigel Brooks, Elaine Kilgour, Paul D Smith. Clin Cancer Res 2012
268
4

Mechanism of FGF receptor dimerization and activation.
Sarvenaz Sarabipour, Kalina Hristova. Nat Commun 2016
119
4

FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
Rui Wang, Lei Wang, Yuan Li, Haichuan Hu, Lei Shen, Xuxia Shen, Yunjian Pan, Ting Ye, Yang Zhang, Xiaoyang Luo,[...]. Clin Cancer Res 2014
95
4

A phase I, first in human study of FP-1039 (GSK3052230), a novel FGF ligand trap, in patients with advanced solid tumors.
A W Tolcher, K P Papadopoulos, A Patnaik, K Wilson, S Thayer, J Zanghi, A T Gemo, W M Kavanaugh, H N Keer, P M LoRusso. Ann Oncol 2016
50
8

FGF Family: From Drug Development to Clinical Application.
Qi Hui, Zi Jin, Xiaokun Li, Changxiao Liu, Xiaojie Wang. Int J Mol Sci 2018
44
9

First-in-Human Phase I Study of Aprutumab Ixadotin, a Fibroblast Growth Factor Receptor 2 Antibody-Drug Conjugate (BAY 1187982) in Patients with Advanced Cancer.
Sung-Bae Kim, Funda Meric-Bernstam, Aparna Kalyan, Aleksei Babich, Rong Liu, Takahiko Tanigawa, Anette Sommer, Motonobu Osada, Frank Reetz, Dirk Laurent,[...]. Target Oncol 2019
16
25

FGF receptors: cancer biology and therapeutics.
Masaru Katoh, Hitoshi Nakagama. Med Res Rev 2014
298
4

Fibroblast growth factor-1 attenuates TGF-β1-induced lung fibrosis.
Chiko Shimbori, Pierre-Simon Bellaye, Jiaji Xia, Jack Gauldie, Kjetil Ask, Carlos Ramos, Carina Becerril, Annie Pardo, Moises Selman, Martin Kolb. J Pathol 2016
57
7

Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth.
Kai Yu, Jingsong Xu, Zhonghao Liu, Drazen Sosic, Jiansu Shao, Eric N Olson, Dwight A Towler, David M Ornitz. Development 2003
453
4


Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion-Positive Cholangiocarcinoma.
Lipika Goyal, Supriya K Saha, Leah Y Liu, Giulia Siravegna, Ignaty Leshchiner, Leanne G Ahronian, Jochen K Lennerz, Phuong Vu, Vikram Deshpande, Avinash Kambadakone,[...]. Cancer Discov 2017
207
4


FGF9 and FGF18 in idiopathic pulmonary fibrosis promote survival and migration and inhibit myofibroblast differentiation of human lung fibroblasts in vitro.
Audrey Joannes, Stéphanie Brayer, Valérie Besnard, Joëlle Marchal-Sommé, Madeleine Jaillet, Pierre Mordant, Hervé Mal, Raphael Borie, Bruno Crestani, Arnaud A Mailleux. Am J Physiol Lung Cell Mol Physiol 2016
44
9

Fibroblast growth factor 2 decreases bleomycin-induced pulmonary fibrosis and inhibits fibroblast collagen production and myofibroblast differentiation.
Hyun Young Koo, Lamis Mf El-Baz, StaceyL House, Sarah N Cilvik, Samuel J Dorry, Nahla M Shoukry, Mohamed L Salem, Hani S Hafez, Nickolai O Dulin, David M Ornitz,[...]. J Pathol 2018
28
14

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer.
N Cihoric, S Savic, S Schneider, I Ackermann, M Bichsel-Naef, R A Schmid, D Lardinois, M Gugger, L Bubendorf, I Zlobec,[...]. Br J Cancer 2014
67
5


FGFR a promising druggable target in cancer: Molecular biology and new drugs.
Rut Porta, Roberto Borea, Andreia Coelho, Shahanavaj Khan, António Araújo, Pablo Reclusa, Tindara Franchina, Nele Van Der Steen, Peter Van Dam, Jose Ferri,[...]. Crit Rev Oncol Hematol 2017
102
4

FGFR1 amplification drives endocrine therapy resistance and is a therapeutic target in breast cancer.
Nicholas Turner, Alex Pearson, Rachel Sharpe, Maryou Lambros, Felipe Geyer, Maria A Lopez-Garcia, Rachael Natrajan, Caterina Marchio, Elizabeth Iorns, Alan Mackay,[...]. Cancer Res 2010
463
4

The FGF system has a key role in regulating vascular integrity.
Masahiro Murakami, Loc T Nguyen, Zhen W Zhuang, Karen L Moodie, Peter Carmeliet, Radu V Stan, Michael Simons. J Clin Invest 2008
209
4

FGF-dependent metabolic control of vascular development.
Pengchun Yu, Kerstin Wilhelm, Alexandre Dubrac, Joe K Tung, Tiago C Alves, Jennifer S Fang, Yi Xie, Jie Zhu, Zehua Chen, Frederik De Smet,[...]. Nature 2017
143
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.